Health IT

Morning Read: Predictive data analysis key to spotting device problems early

A new study in an American Heart Association journal suggest doctors should be using data analysis to predict problems with implanted medial devices instead of relying on patient reporting. The researchers used off-the-shelf surveillance software to monitor large databases of implantable cardioverter-defibrillator patients. They were able to detect problems with recalled leads a year before […]

A new study in an American Heart Association journal suggest doctors should be using data analysis to predict problems with implanted medial devices instead of relying on patient reporting. The researchers used off-the-shelf surveillance software to monitor large databases of implantable cardioverter-defibrillator patients.
They were able to detect problems with recalled leads a year before the manufacturer did.

Bernstein & Co. analyst Jack Scannell isn’t optimistic that biopharmaceutical companies will be able to boost their output any time soon.
From clinging to old-school methods to coping with ever expanding regulations, Scannell’s report finds a lot more problems than solutions.

This weekApple announced tool that is like Remote Desktop for iPads. Configurator will allow IT administrators at large institutions–like hospitals–to manage and configure all the iPads and iPhones in the building.

Sponsored Post

Physician Targeting Using Real-time Data: How PurpleLab’s Alerts Can Help

By leveraging real-time data that offers unprecedented insights into physician behavior and patient outcomes, companies can gain a competitive advantage with prescribers. PurpleLab®, a healthcare analytics platform with one of the largest medical and pharmaceutical claims databases in the United States, recently announced the launch of Alerts which translates complex information into actionable insights, empowering companies to identify the right physicians to target, determine the most effective marketing strategies and ultimately improve patient care.

The Food and Drug Administration is considering a new way to get drugs to the market more quickly by limiting the treatments to specific groups of people.  Antibiotics, weight loss drugs, and other medications could be approved without clinical trials. Dr. Janet Woodcock of the FDA’s Center for Drug Evaluation and Research discussed the idea yesterday during a break in a hearing on FDA user fees and drug approvals.

Venture investment in hospital technology is shifting from cutting-edge robots to more mundane tools to help hospitals fulfill requirements of the health care reform law and avoid financial penalties.  Companies like Castlight Health and Catheter Connections are focused on saving money by helping consumers choose cheaper care and by helping hospitals reduce the cost of cathether-related blood stream infections.